Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Andrew Nierenberg

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Physiology

Drug Resistance

Phenomena

Recurrence

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ostacher Michael J; Lebeau Richard T; Perlis Roy H; Nierenberg Andrew A; Lund Hannah G; Moshier Samantha J; Sachs Gary S; Simon Naomi M
Cigarette smoking is associated with suicidality in bipolar disorder.
Nierenberg Andrew A
What have we learned about bipolar disorder from STEP-BD and other practical trials?
Rush A John; Warden Diane; Wisniewski Stephen R; Fava Maurizio; Trivedi Madhukar H; Gaynes Bradley N; Nierenberg Andrew A
STAR*D: revising conventional wisdom.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Andrew Nierenberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ostacher Michael J; Lebeau Richard T; Perlis Roy H; Nierenberg Andrew A; Lund Hannah G; Moshier Samantha J; Sachs Gary S; Simon Naomi M
Cigarette smoking is associated with suicidality in bipolar disorder.
Bipolar disorders 2009;11(7):766-71.
2009: Nierenberg Andrew A
What have we learned about bipolar disorder from STEP-BD and other practical trials?
The Journal of clinical psychiatry 2009;70(8):e30.
2009: Rush A John; Warden Diane; Wisniewski Stephen R; Fava Maurizio; Trivedi Madhukar H; Gaynes Bradley N; Nierenberg Andrew A
STAR*D: revising conventional wisdom.
CNS drugs 2009;23(8):627-47.
2009: Wisniewski Stephen R; Rush A John; Nierenberg Andrew A; Gaynes Bradley N; Warden Diane; Luther James F; McGrath Patrick J; Lavori Philip W; Thase Michael E; Fava Maurizio; Trivedi Madhukar H
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
The American journal of psychiatry 2009;166(5):599-607.
2009: Warden Diane; Rush A John; Wisniewski Stephen R; Lesser Ira M; Kornstein Susan G; Balasubramani G K; Thase Michael E; Preskorn Sheldon H; Nierenberg Andrew A; Young Elizabeth A; Shores-Wilson Kathy; Trivedi Madhukar H
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(4):459-73.
2009: Husain Mustafa M; Rush A John; Wisniewski Stephen R; McClintock Shawn M; Fava Maurizio; Nierenberg Andrew A; Davis Lori; Balasubramani G K; Young Elizabeth; Albala A Ari; Trivedi Madhukar H
Family history of depression and therapeutic outcome: findings from STAR*D.
The Journal of clinical psychiatry 2009;70(2):185-95.
2009: Warden Diane; Rush A John; Wisniewski Stephen R; Lesser Ira M; Thase Michael E; Balasubramani G K; Shores-Wilson Kathy; Nierenberg Andrew A; Trivedi Madhukar H
Income and attrition in the treatment of depression: a STAR*D report.
Depression and anxiety 2009;26(7):622-33.
2009: Friedman Edward S; Wisniewski Stephen R; Gilmer William; Nierenberg Andrew A; Rush A John; Fava Maurizio; Zisook Sidney; Balasubramani G K; Trivedi Madhukar H
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
Depression and anxiety 2009;26(7):612-21.
2009: Nierenberg Andrew A
Lessons from STEP-BD for the treatment of bipolar depression.
Depression and anxiety 2009;26(2):106-9.
2008: Deckersbach Thilo; Rauch Scott L; Buhlmann Ulrike; Ostacher Michael J; Beucke Jan-Carl; Nierenberg Andrew A; Sachs Gary; Dougherty Darin D
An fMRI investigation of working memory and sadness in females with bipolar disorder: a brief report.
Bipolar disorders 2008;10(8):928-42.
2008: McGrath Patrick J; Khan Ahsan Y; Trivedi Madhukar H; Stewart Jonathan W; Morris David W; Wisniewski Stephen R; Miyahara Sachiko; Nierenberg Andrew A; Fava Maurizio; Rush John A
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
The Journal of clinical psychiatry 2008;69(12):1847-55.
2008: El-Mallakh Rif S; Ghaemi S Nassir; Sagduyu Kemal; Thase Michael E; Wisniewski Stephen R; Nierenberg Andrew A; Zhang Hong Wei; Pardo Tamara A; Sachs Gary;
Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients.
Journal of affective disorders 2008;111(2-3):372-7.
2008: Nierenberg Andrew A
Effective agents in treating bipolar depression.
The Journal of clinical psychiatry 2008;69(10):e29.
2008: Nierenberg Andrew A; Alpert Jonathan E; Gardner-Schuster Erica E; Seay Sheila; Mischoulon David
Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.
Biological psychiatry 2008;64(6):455-60.
2008: Mischoulon David; Best-Popescu Catherine; Laposata Michael; Merens Wendelien; Murakami Jessica L; Wu Shirley L; Papakostas George I; Dording Christina M; Sonawalla Shamsah B; Nierenberg Andrew A; Alpert Jonathan E; Fava Maurizio
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(9):639-45.
2008: Gilmer William S; Gollan Jackie K; Wisniewski Stephen R; Howland Robert H; Trivedi Madhukar H; Miyahara Sachiko; Fleck Jenelle; Thase Michael E; Alpert Jonathan E; Nierenberg Andrew A; Warden Diane; Fava Maurizio; Rush A John
Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.
The Journal of clinical psychiatry 2008;69(8):1246-56.
2008: Rush A John; Wisniewski Stephen R; Warden Diane; Luther James F; Davis Lori L; Fava Maurizio; Nierenberg Andrew A; Trivedi Madhukar H
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Archives of general psychiatry 2008;65(8):870-80.
2008: Ostacher M J; Nierenberg A A; Iosifescu D V; Eidelman P; Lund H G; Ametrano R M; Kaczynski R; Calabrese J; Miklowitz D J; Sachs G S; Perlick D A;
Correlates of subjective and objective burden among caregivers of patients with bipolar disorder.
Acta psychiatrica Scandinavica 2008;118(1):49-56.
2008: Iosifescu Dan V; Bolo Nicolas R; Nierenberg Andrew A; Jensen J Eric; Fava Maurizio; Renshaw Perry F
Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder.
Biological psychiatry 2008;63(12):1127-34.
2008: Taylor Charles T; Hirshfeld-Becker Dina R; Ostacher Michael J; Chow Candice W; LeBeau Richard T; Pollack Mark H; Nierenberg Andrew A; Simon Naomi M
Anxiety is associated with impulsivity in bipolar disorder.
Journal of anxiety disorders 2008;22(5):868-76.
2008: Nierenberg Andrew A
Major depressive disorder: epidemiology, course of illness, and treatment.
CNS spectrums 2008;13(5 Suppl 8):4-7.
2008: Huffman Jeffery C; Park Lawrence T; Welch Charles A; Nierenberg Andrew A; Januzzi James L; Pomerantz Stuart R
Case records of the Massachusetts General Hospital. Case 14-2008. A 78-year-old man with anergia and anhedonia associated with cardiovascular surgery.
The New England journal of medicine 2008;358(19):2051-9.
2008: Gaynes Bradley N; Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Balasubramani G K; McGrath Patrick J; Thase Michael E; Klinkman Michael; Nierenberg Andrew A; Yates William R; Fava Maurizio
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
Journal of general internal medicine 2008;23(5):551-60.
2008: Nierenberg Andrew A; Alpert Jonathan E; Gaynes Bradley N; Warden Diane; Wisniewski Stephen R; Biggs Melanie M; Trivedi Madhukar H; Barkin Jennifer L; Rush A John
Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
Journal of affective disorders 2008;108(1-2):129-34.
2008: Nierenberg Andrew A; Ostacher Michael J; Huffman Jeffrey C; Ametrano Rebecca M; Fava Maurizio; Perlis Roy H
A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2008;50(4):428-36.
2008: Simon N M; McNamara K; Chow C W; Maser R S; Papakostas G I; Pollack M H; Nierenberg A A; Fava M; Wong K K
A detailed examination of cytokine abnormalities in Major Depressive Disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(3):230-3.
2008: Nierenberg Andrew A
An analysis of the efficacy of treatments for bipolar depression.
The Journal of clinical psychiatry 2008;69 Suppl 5():4-8.
2008: Howland Robert H; Schettler Pamela J; Rapaport Mark Hyman; Mischoulon David; Schneider Trisha; Fasiczka Amy; Delrahiem Katia; Maddux Rachel; Lightfoot Michael; Nierenberg Andrew A
Clinical features and functioning of patients with minor depression.
Psychotherapy and psychosomatics 2008;77(6):384-9.
2008: Lipkovich Ilya; Mallinckrodt Craig H; Prakash Apurva; Nierenberg Andrew A
Addressing methodological issues in studying antidepressant onset efficacy using prespecified sensitivity analyses.
Psychopharmacology bulletin 2008;41(2):40-54.
2008: Nierenberg Andrew A; Smoller Jordan W; Eidelman Polina; Wu Yelena P; Tilley Claire A
Critical thinking about adverse drug effects: lessons from the psychology of risk and medical decision-making for clinical psychopharmacology.
Psychotherapy and psychosomatics 2008;77(4):201-8.
2007: Zisook Sidney; Lesser Ira; Stewart Jonathan W; Wisniewski Stephen R; Balasubramani G K; Fava Maurizio; Gilmer William S; Dresselhaus Timothy R; Thase Michael E; Nierenberg Andrew A; Trivedi Madhukar H; Rush A John
Effect of age at onset on the course of major depressive disorder.
The American journal of psychiatry 2007;164(10):1539-46.
2007: Reilly-Harrington Noreen A; Deckersbach Thilo; Knauz Robert; Wu Yelena; Tran Tanya; Eidelman Polina; Lund Hannah G; Sachs Gary; Nierenberg Andrew A
Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study.
Journal of psychiatric practice 2007;13(5):291-7.
2007: Warden Diane; Trivedi Madhukar H; Wisniewski Stephen R; Davis Lori; Nierenberg Andrew A; Gaynes Bradley N; Zisook Sidney; Hollon Steven D; Balasubramani G K; Howland Robert; Fava Maurizio; Stewart Jonathan W; Rush A John
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.
The American journal of psychiatry 2007;164(8):1189-97.
2007: Thase Michael E; Friedman Edward S; Biggs Melanie M; Wisniewski Stephen R; Trivedi Madhukar H; Luther James F; Fava Maurizio; Nierenberg Andrew A; McGrath Patrick J; Warden Diane; Niederehe George; Hollon Steven D; Rush A John
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
The American journal of psychiatry 2007;164(5):739-52.
2007: Michelson David; Adler Lenard A; Amsterdam Jay D; Dunner David L; Nierenberg Andrew A; Reimherr Frederick W; Schatzberg Alan F; Kelsey Douglas K; Williams David W
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
The Journal of clinical psychiatry 2007;68(4):582-7.
2007: Miklowitz David J; Otto Michael W; Frank Ellen; Reilly-Harrington Noreen A; Wisniewski Stephen R; Kogan Jane N; Nierenberg Andrew A; Calabrese Joseph R; Marangell Lauren B; Gyulai Laszlo; Araga Mako; Gonzalez Jodi M; Shirley Edwin R; Thase Michael E; Sachs Gary S
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.
Archives of general psychiatry 2007;64(4):419-26.
2007: Sachs Gary S; Nierenberg Andrew A; Calabrese Joseph R; Marangell Lauren B; Wisniewski Stephen R; Gyulai Laszlo; Friedman Edward S; Bowden Charles L; Fossey Mark D; Ostacher Michael J; Ketter Terence A; Patel Jayendra; Hauser Peter; Rapport Daniel; Martinez James M; Allen Michael H; Miklowitz David J; Otto Michael W; Dennehy Ellen B; Thase Michael E
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
The New England journal of medicine 2007;356(17):1711-22.
2007: Simon Naomi M; Zalta Alyson K; Otto Michael W; Ostacher Michael J; Fischmann Diana; Chow Candice W; Thompson Elizabeth H; Stevens Julie C; Demopulos Christina M; Nierenberg Andrew A; Pollack Mark H
The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder.
Journal of psychiatric research 2007;41(3-4):255-64.
2007: Henin Aude; Biederman Joseph; Mick Eric; Hirshfeld-Becker Dina R; Sachs Gary S; Wu Yelena; Yan Leslie; Ogutha Jacqueline; Nierenberg Andrew A
Childhood antecedent disorders to bipolar disorder in adults: a controlled study.
Journal of affective disorders 2007;99(1-3):51-7.
2007: Nierenberg Andrew A; Trivedi Madhukar H; Fava Maurizio; Biggs Melanie M; Shores-Wilson Kathy; Wisniewski Stephen R; Balasubramani G K; Rush A John
Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
Journal of psychiatric research 2007;41(3-4):214-21.
2007: Nierenberg Andrew A; Katz Judith; Fava Maurizio
A critical overview of the pharmacologic management of treatment-resistant depression.
The Psychiatric clinics of North America 2007;30(1):13-29.
2007: Nierenberg Andrew A
A counter proposal to manage financial conflicts of interest in academic psychiatry.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2007;6(1):34-6.
2007: Iosifescu Dan V; Renshaw Perry F; Dougherty Darin D; Lyoo In Kyoon; Lee Ho Kyu; Fraguas Renerio; Cassano Paolo; Nierenberg Andrew A; Fava Maurizio
Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities.
The Journal of nervous and mental disease 2007;195(2):175-8.
2007: Nierenberg Andrew A; Greist John H; Mallinckrodt Craig H; Prakash Apurva; Sambunaris Angelo; Tollefson Gary D; Wohlreich Madelaine M
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Current medical research and opinion 2007;23(2):401-16.
2007: Nierenberg Andrew A
Combined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigine.
Evidence-based mental health 2007;10(1):12.
2007: Kobak Kenneth A; Kane John M; Thase Michael E; Nierenberg Andrew A
Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?
Journal of clinical psychopharmacology 2007;27(1):1-5.
2007: Papakostas George I; Petersen Timothy; Sklarsky Katherine G; Nierenberg Andrew A; Alpert Jonathan E; Fava Maurizio
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.
Psychiatry research 2007;149(1-3):195-200.
2007: Simon Naomi M; Pollack Mark H; Ostacher Michael J; Zalta Alyson K; Chow Candice W; Fischmann Diana; Demopulos Christina M; Nierenberg Andrew A; Otto Michael W
Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder.
Journal of affective disorders 2007;97(1-3):91-9.
2006: Ostacher Michael J; Nierenberg Andrew A; Perlis Roy H; Eidelman Polina; Borrelli David J; Tran Tanya B; Marzilli Ericson Gianna; Weiss Roger D; Sachs Gary S
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder.
The Journal of clinical psychiatry 2006;67(12):1907-11.
2006: Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Nierenberg Andrew A; Stewart Jonathan W; Warden Diane; Niederehe George; Thase Michael E; Lavori Philip W; Lebowitz Barry D; McGrath Patrick J; Rosenbaum Jerrold F; Sackeim Harold A; Kupfer David J; Luther James; Fava Maurizio
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
The American journal of psychiatry 2006;163(11):1905-17.
2006: Marangell Lauren B; Suppes Trisha; Ketter Terence A; Dennehy Ellen B; Zboyan Holly; Kertz Barbara; Nierenberg Andrew; Calabrese Joseph; Wisniewski Stephen R; Sachs Gary
Omega-3 fatty acids in bipolar disorder: clinical and research considerations.
Prostaglandins, leukotrienes, and essential fatty acids 2006;75(4-5):315-21.
2006: McGrath Patrick J; Stewart Jonathan W; Quitkin Frederic M; Chen Ying; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio; Cheng Jianfeng; Petkova Eva
Predictors of relapse in a prospective study of fluoxetine treatment of major depression.
The American journal of psychiatry 2006;163(9):1542-8.
2006: McGrath Patrick J; Stewart Jonathan W; Fava Maurizio; Trivedi Madhukar H; Wisniewski Stephen R; Nierenberg Andrew A; Thase Michael E; Davis Lori; Biggs Melanie M; Shores-Wilson Kathy; Luther James F; Niederehe George; Warden Diane; Rush A John
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1531-41; quiz 1666.
2006: Nierenberg Andrew A; Fava Maurizio; Trivedi Madhukar H; Wisniewski Stephen R; Thase Michael E; McGrath Patrick J; Alpert Jonathan E; Warden Diane; Luther James F; Niederehe George; Lebowitz Barry; Shores-Wilson Kathy; Rush A John
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1519-30; quiz 1665.
2006: Simon Naomi M; Smoller Jordan W; McNamara Kate L; Maser Richard S; Zalta Alyson K; Pollack Mark H; Nierenberg Andrew A; Fava Maurizio; Wong Kwok-Kin
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.
Biological psychiatry 2006;60(5):432-5.
2006: Denninger John W; Papakostas George I; Mahal Yasmin; Merens Wendelien; Alpert Jonathan E; Nierenberg Andrew A; Yeung Albert; Fava Maurizio
Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine.
Psychosomatics 2006;47(4):348-52.
2006: Otto M W; Simon N M; Wisniewski S R; Miklowitz D J; Kogan J N; Reilly-Harrington N A; Frank E; Nierenberg A A; Marangell L B; Sagduyu K; Weiss R D; Miyahara S; Thas M E; Sachs G S; Pollack M H;
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.
The British journal of psychiatry : the journal of mental science 2006;189():20-5.
2006: Fava Maurizio; Rush A John; Wisniewski Stephen R; Nierenberg Andrew A; Alpert Jonathan E; McGrath Patrick J; Thase Michael E; Warden Diane; Biggs Melanie; Luther James F; Niederehe George; Ritz Louise; Trivedi Madhukar H
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
The American journal of psychiatry 2006;163(7):1161-72.
2006: Ghaemi S Nassir; Hsu Douglas J; Thase Michael E; Wisniewski Stephen R; Nierenberg Andrew A; Miyahara Sachiko; Sachs Gary
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
Psychiatric services (Washington, D.C.) 2006;57(5):660-5.
2006: Khan Ahsan Y; Carrithers Joe; Preskorn Sheldon H; Lear Rex; Wisniewski Stephen R; John Rush A; Stegman Diane; Kelley Colleen; Kreiner Karen; Nierenberg Andrew A; Fava Maurizio
Clinical and demographic factors associated with DSM-IV melancholic depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2006;18(2):91-8.
2006: Eden Evins A; Demopulos Christina; Yovel Iftah; Culhane Melissa; Ogutha Jacqueline; Grandin Louisa D; Nierenberg Andrew A; Sachs Gary S
Inositol augmentation of lithium or valproate for bipolar depression.
Bipolar disorders 2006;8(2):168-74.
2006: Wisniewski Stephen R; Rush A John; Balasubramani G K; Trivedi Madhukar H; Nierenberg Andrew A;
Self-rated global measure of the frequency, intensity, and burden of side effects.
Journal of psychiatric practice 2006;12(2):71-9.
2006: Pollack Mark H; Simon Naomi M; Fagiolini Andrea; Pitman Roger; McNally Richard J; Nierenberg Andrew A; Miyahara Sachicko; Sachs Gary S; Perlman Carol; Ghaemi S Nassir; Thase Michael E; Otto Michael W
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.
The Journal of clinical psychiatry 2006;67(3):394-9.
2006: Trivedi Madhukar H; Fava Maurizio; Wisniewski Stephen R; Thase Michael E; Quitkin Frederick; Warden Diane; Ritz Louise; Nierenberg Andrew A; Lebowitz Barry D; Biggs Melanie M; Luther James F; Shores-Wilson Kathy; Rush A John;
Medication augmentation after the failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1243-52.
2006: Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Stewart Jonathan W; Nierenberg Andrew A; Thase Michael E; Ritz Louise; Biggs Melanie M; Warden Diane; Luther James F; Shores-Wilson Kathy; Niederehe George; Fava Maurizio;
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1231-42.
2006: Rush A John; Bernstein Ira H; Trivedi Madhukar H; Carmody Thomas J; Wisniewski Stephen; Mundt James C; Shores-Wilson Kathy; Biggs Melanie M; Woo Ada; Nierenberg Andrew A; Fava Maurizio
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
Biological psychiatry 2006;59(6):493-501.
2006: Trivedi Madhukar H; Rush A John; Wisniewski Stephen R; Warden Diane; McKinney William; Downing Michael; Berman Susan R; Farabaugh Amy; Luther James F; Nierenberg Andrew A; Callan Judith A; Sackeim Harold A
Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.
The Journal of clinical psychiatry 2006;67(2):185-95.
2006: Iosifescu Dan V; Renshaw Perry F; Lyoo In Kyoon; Lee Ho Kyu; Perlis Roy H; Papakostas George I; Nierenberg Andrew A; Fava Maurizio
Brain white-matter hyperintensities and treatment outcome in major depressive disorder.
The British journal of psychiatry : the journal of mental science 2006;188():180-5.
2006: Perlis Roy H; Brown Eileen; Baker Robert W; Nierenberg Andrew A
Clinical features of bipolar depression versus major depressive disorder in large multicenter trials.
The American journal of psychiatry 2006;163(2):225-31.
2006: Perlis Roy H; Ostacher Michael J; Patel Jayendra K; Marangell Lauren B; Zhang Hongwei; Wisniewski Stephen R; Ketter Terence A; Miklowitz David J; Otto Michael W; Gyulai Laszlo; Reilly-Harrington Noreen A; Nierenberg Andrew A; Sachs Gary S; Thase Michael E
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
The American journal of psychiatry 2006;163(2):217-24.
2006: Nierenberg Andrew A; Ostacher Michael J; Calabrese Joseph R; Ketter Terence A; Marangell Lauren B; Miklowitz David J; Miyahara Sachiko; Bauer Mark S; Thase Michael E; Wisniewski Stephen R; Sachs Gary S
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
The American journal of psychiatry 2006;163(2):210-6.
2006: Eden Evins A; Demopulos Christina; Nierenberg Andrew; Culhane Melissa A; Eisner Lori; Sachs Gary
A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
Bipolar disorders 2006;8(1):75-80.
2006: Hollon Steven D; Shelton Richard C; Wisniewski Stephen; Warden Diane; Biggs Melanie M; Friedman Edward S; Husain Mustafa; Kupfer David J; Nierenberg Andrew A; Petersen Timothy J; Shores-Wilson Kathy; Rush A John
Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial.
Journal of psychiatric research 2006;40(1):59-69.
2006: Trivedi Madhukar H; Rush A John; Wisniewski Stephen R; Nierenberg Andrew A; Warden Diane; Ritz Louise; Norquist Grayson; Howland Robert H; Lebowitz Barry; McGrath Patrick J; Shores-Wilson Kathy; Biggs Melanie M; Balasubramani G K; Fava Maurizio;
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
The American journal of psychiatry 2006;163(1):28-40.
2006: Deckersbach Thilo; Dougherty Darin D; Savage Cary; McMurrich Stephanie; Fischman Alan J; Nierenberg Andrew; Sachs Gary; Rauch Scott L
Impaired recruitment of the dorsolateral prefrontal cortex and hippocampus during encoding in bipolar disorder.
Biological psychiatry 2006;59(2):138-46.
2006: Nierenberg Andrew A; Ostacher Michael J; Borrelli David J; Iosifescu Dan V; Perlis Roy H; Desrosiers Astrid; Armistead Molly S; Calkins Amanda W; Sachs Gary S
The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry.
The Journal of clinical psychiatry 2006;67 Suppl 11():3-7.
2005: Iosifescu Dan V; Papakostas George I; Lyoo In Kyoon; Lee Ho Kyu; Renshaw Perry F; Alpert Jonathan E; Nierenberg Andrew; Fava Maurizio
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I).
Psychiatry research 2005;140(3):291-9.
2005: Papakostas George I; Iosifescu Dan V; Renshaw Perry F; Lyoo In Kyoon; Lee Ho Kyu; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II).
Psychiatry research 2005;140(3):301-7.
2005: Papakostas George I; Petersen Timothy; Lebowitz Barry D; Mischoulon David; Ryan Julie L; Nierenberg Andrew A; Bottiglieri Teodoro; Alpert Jonathan E; Rosenbaum Jerrold F; Fava Maurizio
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(4):523-8.
2005: Papakostas George I; Petersen Timothy J; Kinrys Gustavo; Burns Alana M; Worthington John J; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2005;66(10):1326-30.
2005: Perlis Roy H; Perlis Clifford S; Wu Yelena; Hwang Cindy; Joseph Megan; Nierenberg Andrew A
Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
The American journal of psychiatry 2005;162(10):1957-60.
2005: Perlis Roy H; Delbello Melissa P; Miyahara Sachiko; Wisniewski Stephen R; Sachs Gary S; Nierenberg Andrew A;
Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participants.
Biological psychiatry 2005;58(7):549-53.
2005: Fava Maurizio; Alpert Jonathan; Nierenberg Andrew A; Mischoulon David; Otto Michael W; Zajecka John; Murck Harald; Rosenbaum Jerrold F
A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Journal of clinical psychopharmacology 2005;25(5):441-7.
2005: Henin Aude; Biederman Joseph; Mick Eric; Sachs Gary S; Hirshfeld-Becker Dina R; Siegel Rebecca S; McMurrich Stephanie; Grandin Louisa; Nierenberg Andrew A
Psychopathology in the offspring of parents with bipolar disorder: a controlled study.
Biological psychiatry 2005;58(7):554-61.
2005: Iosifescu Dan V; Clementi-Craven Nicoletta; Fraguas Renerio; Papakostas George I; Petersen Timothy; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder.
Psychosomatic medicine 2005;67(5):703-6.
2005: Simon Naomi M; Pollack Mark H; Fischmann Diana; Perlman Carol A; Muriel Anna C; Moore Cynthia W; Nierenberg Andrew A; Shear M Katherine
Complicated grief and its correlates in patients with bipolar disorder.
The Journal of clinical psychiatry 2005;66(9):1105-10.
2005: Rush A John; Marangell Lauren B; Sackeim Harold A; George Mark S; Brannan Stephen K; Davis Sonia M; Howland Robert; Kling Mitchel A; Rittberg Barry R; Burke William J; Rapaport Mark H; Zajecka John; Nierenberg Andrew A; Husain Mustafa M; Ginsberg David; Cooke Robert G
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
Biological psychiatry 2005;58(5):347-54.
2005: Iosifescu Dan V; Nierenberg Andrew A; Mischoulon David; Perlis Roy H; Papakostas George I; Ryan Julie L; Alpert Jonathan E; Fava Maurizio
An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2005;66(8):1038-42.
2005: Novick Jon S; Stewart Jonathan W; Wisniewski Stephen R; Cook Ian A; Manev Radmila; Nierenberg Andrew A; Rosenbaum Jerrold F; Shores-Wilson Kathy; Balasubramani G K; Biggs Melanie M; Zisook Sid; Rush A John;
Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D.
The Journal of clinical psychiatry 2005;66(8):1002-11.
2005: Petersen Timothy; Papakostas George I; Posternak Michael A; Kant Alexis; Guyker Wendy M; Iosifescu Dan V; Yeung Albert S; Nierenberg Andrew A; Fava Maurizio
Empirical testing of two models for staging antidepressant treatment resistance.
Journal of clinical psychopharmacology 2005;25(4):336-41.
2005: Papakostas George I; Petersen Timothy J; Green Cassandra; Iosifescu Dan V; Yeung Albert S; Nierenberg Andrew A; Fava Maurizio; Posternak Michael A
A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinic.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2005;17(3):161-5.
2005: Simon Naomi M; Otto Michael W; Fischmann Diana; Racette Stephanie; Nierenberg Andrew A; Pollack Mark H; Smoller Jordan W
Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states.
Journal of affective disorders 2005;87(1):101-5.
2005: Weiss Roger D; Ostacher Michael J; Otto Michael W; Calabrese Joseph R; Fossey Mark; Wisniewski Stephen R; Bowden Charles L; Nierenberg Andrew A; Pollack Mark H; Salloum Ihsan M; Simon Naomi M; Thase Michael E; Sachs Gary S;
Does recovery from substance use disorder matter in patients with bipolar disorder?
The Journal of clinical psychiatry 2005;66(6):730-5; quiz 808-9.
2005: Nierenberg Andrew A; Miyahara Sachiko; Spencer Tom; Wisniewski Stephen R; Otto Michael W; Simon Naomi; Pollack Mark H; Ostacher Michael J; Yan Leslie; Siegel Rebecca; Sachs Gary S;
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
Biological psychiatry 2005;57(11):1467-73.
2005: Murck Harald; Fava Maurizio; Alpert Jonathan; Nierenberg Andrew A; Mischoulon David; Otto Michael W; Zajecka John; Mannel Marcus; Rosenbaum Jerrold F
Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(2):215-21.
2005: Hollon Steven D; Jarrett Robin B; Nierenberg Andrew A; Thase Michael E; Trivedi Madhukar; Rush A John
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?
The Journal of clinical psychiatry 2005;66(4):455-68.
2005: Deckersbach Thilo; Savage Cary R; Dougherty Darin D; Bohne Antje; Loh Rebecca; Nierenberg Andrew; Sachs Gary; Rauch Scott L
Spontaneous and directed application of verbal learning strategies in bipolar disorder and obsessive-compulsive disorder.
Bipolar disorders 2005;7(2):166-75.
2005: Papakostas George I; Petersen Timothy; Iosifescu Dan V; Burns Alana M; Nierenberg Andrew A; Alpert Jonathan E; Rosenbaum Jerrold F; Fava Maurizio
Obesity among outpatients with major depressive disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(1):59-63.
2005: Yeung Albert; Kung Winnie W; Murakami Jessica L; Mischoulon David; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Outcomes of recognizing depressed Chinese American patients in primary care.
International journal of psychiatry in medicine 2005;35(3):213-24.
2005: Mansour Hader A; Talkowski Michael E; Wood Joel; Pless Lora; Bamne Mikhil; Chowdari Kodavali V; Allen Michael; Bowden Charles L; Calabrese Joseph; El-Mallakh Rif S; Fagiolini Andrea; Faraone Stephen V; Fossey Mark D; Friedman Edward S; Gyulai Laszlo; Hauser Peter; Ketter Terence A; Loftis Jennifer M; Marangell Lauren B; Miklowitz David J; Nierenberg Andrew A; Patel Jayendra; Sachs Gary S; Sklar Pamela; Smoller Jordan W; Thase Michael E; Frank Ellen; Kupfer David J; Nimgaonkar Vishwajit L
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.
Annals of medicine 2005;37(8):590-602.
2004: Simon Naomi M; Otto Michael W; Wisniewski Stephen R; Fossey Mark; Sagduyu Kemal; Frank Ellen; Sachs Gary S; Nierenberg Andrew A; Thase Michael E; Pollack Mark H
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
The American journal of psychiatry 2004;161(12):2222-9.
2004: Alpert Jonathan E; Papakostas George; Mischoulon David; Worthington John J; Petersen Timothy; Mahal Yasmin; Burns Alana; Bottiglieri Teodoro; Nierenberg Andrew A; Fava Maurizio
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.
Journal of clinical psychopharmacology 2004;24(6):661-4.
2004: Nierenberg Andrew A; Trivedi Madhukar H; Ritz Louise; Burroughs Diane; Greist John; Sackeim Harold; Kornstein Susan; Schwartz Terry; Stegman Diane; Fava Maurizio; Wisniewski Stephen R
Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines.
Journal of psychiatric research 2004;38(6):583-9.
2004: Simon Naomi M; Otto Michael W; Weiss Roger D; Bauer Mark S; Miyahara Sachiko; Wisniewski Stephen R; Thase Michael E; Kogan Jane; Frank Ellen; Nierenberg Andrew A; Calabrese Joseph R; Sachs Gary S; Pollack Mark H;
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
Journal of clinical psychopharmacology 2004;24(5):512-20.
2004: Papakostas George I; Petersen Timothy; Denninger John W; Tossani Eliana; Pava Joel A; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Psychosocial functioning during the treatment of major depressive disorder with fluoxetine.
Journal of clinical psychopharmacology 2004;24(5):507-11.
2004: Iosifescu Dan V; Nierenberg Andrew A; Alpert Jonathan E; Papakostas George I; Perlis Roy H; Sonawalla Shamsah; Fava Maurizio
Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment.
Psychosomatics 2004;45(5):419-25.
2004: Papakostas George I; Petersen Timothy; Mischoulon David; Green Cassandra H; Nierenberg Andrew A; Bottiglieri Teodoro; Rosenbaum Jerrold F; Alpert Jonathan E; Fava Maurizio
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy.
The Journal of clinical psychiatry 2004;65(8):1096-8.
2004: Papakostas George I; Petersen Timothy; Mischoulon David; Ryan Julie L; Nierenberg Andrew A; Bottiglieri Teodoro; Rosenbaum Jerrold F; Alpert Jonathan E; Fava Maurizio
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.
The Journal of clinical psychiatry 2004;65(8):1090-5.
2004: Papakostas George I; Iosifescu Dan V; Petersen Timothy; Hamill Sarah K; Alpert Jonathan E; Nierenberg Andrew A; Rosenbaum Jerrold F; Fava Maurizio
Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorder.
Journal of clinical psychopharmacology 2004;24(4):467-9.
2004: Petersen Timothy; Papakostas George I; Mahal Yasmin; Guyker Wendy M; Beaumont Erin C; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
Psychosocial functioning in patients with treatment resistant depression.
European psychiatry : the journal of the Association of European Psychiatrists 2004;19(4):196-201.
2004: Nierenberg Andrew A; Sonino Nicoletta
From clinical observations to clinimetrics: a tribute to Alvan R. Feinstein, MD.
Psychotherapy and psychosomatics 2004;73(3):131-3.
2004: Papakostas George I; Petersen Timothy; Hughes Megan E; Nierenberg Andrew A; Alpert Jonathan E; Fava Maurizio
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder.
Psychiatry research 2004;126(3):287-90.
2004: Perlis Roy H; Iosifescu Dan V; Alpert Jonathan; Nierenberg Andrew A; Rosenbaum Jerrold F; Fava Maurizio
Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression.
Psychosomatics 2004;45(3):224-9.
2004: Perlis Roy H; Miyahara Sachiko; Marangell Lauren B; Wisniewski Stephen R; Ostacher Michael; DelBello Melissa P; Bowden Charles L; Sachs Gary S; Nierenberg Andrew A;
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Biological psychiatry 2004;55(9):875-81.
2004: Nierenberg Andrew A; Quitkin Frederic M; Kremer Charlotte; Keller Martin B; Thase Michael E
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(5):1012-8.
2004: Papakostas George I; Petersen Timothy J; Iosifescu Dan V; Summergrad Paul; Sklarsky Katherine G; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder.
The Journal of clinical psychiatry 2004;65(4):543-6.
2004: Yeung Albert; Chang Doris; Gresham Robert L; Nierenberg Andrew A; Fava Maurizio
Illness beliefs of depressed Chinese American patients in primary care.
The Journal of nervous and mental disease 2004;192(4):324-7.
2004: Perlis Roy H; Smoller Jordan W; Fava Maurizio; Rosenbaum Jerrold F; Nierenberg Andrew A; Sachs Gary S
The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder.
Journal of affective disorders 2004;79(1-3):291-5.
2004: Deckersbach Thilo; Perlis Roy H; Frankle W Gordon; Gray Stephen M; Grandin Louisa; Dougherty Darin D; Nierenberg Andrew A; Sachs Gary S
Presence of irritability during depressive episodes in bipolar disorder.
CNS spectrums 2004;9(3):227-31.
2004: Rush A John; Fava Maurizio; Wisniewski Stephen R; Lavori Philip W; Trivedi Madhukar H; Sackeim Harold A; Thase Michael E; Nierenberg Andrew A; Quitkin Frederic M; Kashner T Michael; Kupfer David J; Rosenbaum Jerrold F; Alpert Jonathan; Stewart Jonathan W; McGrath Patrick J; Biggs Melanie M; Shores-Wilson Kathy; Lebowitz Barry D; Ritz Louise; Niederehe George;
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Controlled clinical trials 2004;25(1):119-42.
2004: Papakostas George I; Petersen Timothy J; Nierenberg Andrew A; Murakami Jessica L; Alpert Jonathan E; Rosenbaum Jerrold F; Fava Maurizio
Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.
The Journal of clinical psychiatry 2004;65(2):217-21.
2004: Yeung Albert; Chan Raymond; Mischoulon David; Sonawalla Shamsah; Wong Eileen; Nierenberg Andrew A; Fava Maurizio
Prevalence of major depressive disorder among Chinese-Americans in primary care.
General hospital psychiatry 2004;26(1):24-30.
2004: Papakostas George I; Petersen Timothy; Mahal Yasmin; Mischoulon David; Nierenberg Andrew A; Fava Maurizio
Quality of life assessments in major depressive disorder: a review of the literature.
General hospital psychiatry 2004;26(1):13-7.
2003: Dougherty Darin D; Weiss Anthony P; Cosgrove G Rees; Alpert Nathaniel M; Cassem Edwin H; Nierenberg Andrew A; Price Bruce H; Mayberg Helen S; Fischman Alan J; Rauch Scott L
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression.
Journal of neurosurgery 2003;99(6):1010-7.
2003: Iosifescu Dan V; Nierenberg Andrew A; Alpert Jonathan E; Smith Megan; Bitran Stella; Dording Christina; Fava Maurizio
The impact of medical comorbidity on acute treatment in major depressive disorder.
The American journal of psychiatry 2003;160(12):2122-7.
2003: Perlis R H; Alpert J; Nierenberg A A; Mischoulon D; Yeung A; Rosenbaum J F; Fava M
Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day.
Acta psychiatrica Scandinavica 2003;108(6):432-8.
2003: Papakostas George I; Petersen Timothy J; Farabaugh Amy H; Murakami Jessica L; Pava Joel A; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2003;64(11):1357-61.
2003: Papakostas George I; Petersen Timothy; Denninger John W; Montoya Heidi D; Nierenberg Andrew A; Alpert Jonathan E; Fava Maurizio
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2003;15(3-4):187-92.
2003: Papakostas George I; Petersen Timothy; Worthington John J; Roffi Pamela A; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed.
International clinical psychopharmacology 2003;18(5):293-6.
2003: Papakostas George I; Petersen Timothy; Pava Joel; Masson Ella; Worthington John J; Alpert Jonathan E; Fava Maruizio; Nierenberg Andrew A
Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcome.
The Journal of nervous and mental disease 2003;191(7):444-9.
2003: Sachs Gary S; Thase Michael E; Otto Michael W; Bauer Mark; Miklowitz David; Wisniewski Stephen R; Lavori Philip; Lebowitz Barry; Rudorfer Mathew; Frank Ellen; Nierenberg Andrew A; Fava Maurizio; Bowden Charles; Ketter Terence; Marangell Lauren; Calabrese Joseph; Kupfer David; Rosenbaum Jerrold F
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Biological psychiatry 2003;53(11):1028-42.
2003: Fava Maurizio; Rush A John; Trivedi Madhukar H; Nierenberg Andrew A; Thase Michael E; Sackeim Harold A; Quitkin Frederic M; Wisniewski Steven; Lavori Philip W; Rosenbaum Jerrold F; Kupfer David J
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
The Psychiatric clinics of North America 2003;26(2):457-94, x.
2003: Nierenberg Andrew A
Predictors of response to antidepressants general principles and clinical implications.
The Psychiatric clinics of North America 2003;26(2):345-52, viii.
2003: Papakostas George I; Petersen Timothy; Iosifescu Dan V; Roffi Pamela A; Alpert Jonathan E; Rosenbaum Jerrold F; Fava Maurizio; Nierenberg Andrew A
Axis III disorders in treatment-resistant major depressive disorder.
Psychiatry research 2003;118(2):183-8.
2003: Papakostas George I; Petersen Timothy; Mischoulon David; Hughes Megan E; Alpert Jonathan E; Nierenberg Andrew A; Rosenbaum Jerrold F; Fava Maurizio
Serum cholesterol and serotonergic function in major depressive disorder.
Psychiatry research 2003;118(2):137-45.
2003: Papakostas George I; Petersen Timothy; Denninger John; Sonawalla Shamsah B; Mahal Yasmin; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Somatic symptoms in treatment-resistant depression.
Psychiatry research 2003;118(1):39-45.
2003: Alpert Jonathan E; Petersen Timothy; Roffi Pamela A; Papakostas George I; Freed Rachel; Smith Megan M; Spector Andrew R; Nierenberg Andrew A; Rosenbaum Jerrold F; Fava Maurizio
Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks.
Psychotherapy and psychosomatics 2003;72(2):102-6.
2003: Nierenberg Andrew A; Papakostas George I; Petersen Timothy; Montoya Heidi D; Worthington John J; Tedlow Joyce; Alpert Jonathan E; Fava Maurizio
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.
Journal of clinical psychopharmacology 2003;23(1):92-5.
2003: Nierenberg Andrew A; Papakostas George I; Petersen Timothy; Kelly Karen E; Iacoviello Brian M; Worthington John J; Tedlow Joyce; Alpert Jonathan E; Fava Maurizio
Nortriptyline for treatment-resistant depression.
The Journal of clinical psychiatry 2003;64(1):35-9.
2003: Papakostas George I; Petersen Timothy; Mischoulon David; Hughes Megan E; Spector Andrew R; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.
Comprehensive psychiatry 2003;44(1):44-50.
2003: Nierenberg Andrew A; Petersen Timothy J; Alpert Jonathan E
Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy.
The Journal of clinical psychiatry 2003;64 Suppl 15():13-7.
2003: Papakostas George I; Petersen Timothy; Sonawalla Shamsah B; Merens Wendelien; Iosifescu Dan V; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
Serum cholesterol in treatment-resistant depression.
Neuropsychobiology 2003;47(3):146-51.
2002: Frankle W G; Perlis R H; Deckersbach T; Grandin L D; Gray S M; Sachs G S; Nierenberg A A
Bipolar depression: relationship between episode length and antidepressant treatment.
Psychological medicine 2002;32(8):1417-23.
2002: Perlis Roy H; Nierenberg Andrew A; Alpert Jonathan E; Pava Joel; Matthews John D; Buchin Jaqueline; Sickinger Andrea H; Fava Maurizio
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.
Journal of clinical psychopharmacology 2002;22(5):474-80.
2002: Dording Christina M; Mischoulon David; Petersen Timothy J; Kornbluh Rebecca; Gordon Johanna; Nierenberg Andrew A; Rosenbaum Jerrold E; Fava Maurizio
The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2002;14(3):143-7.
2002: Tedlow Joyce; Smith Megan; Neault Nicole; Polania Laura; Alpert Jonathan; Nierenberg Andrew; Fava Maurizio
Melancholia and axis II comorbidity.
Comprehensive psychiatry 2002;43(5):331-5.
2002: Petersen Timothy; Hughes Megan; Papakostas George I; Kant Alexis; Fava Maurizio; Rosenbaum Jerrold F; Nierenberg Andrew A
Treatment-resistant depression and Axis II comorbidity.
Psychotherapy and psychosomatics 2002;71(5):269-74.
2002: Otto Michael W; Nierenberg Andrew A
Assay sensitivity, failed clinical trials, and the conduct of science.
Psychotherapy and psychosomatics 2002;71(5):241-3.
2002: Fava M; Farabaugh A H; Sickinger A H; Wright E; Alpert J E; Sonawalla S; Nierenberg A A; Worthington J J
Personality disorders and depression.
Psychological medicine 2002;32(6):1049-57.
2002: Montgomery Stuart A; Bech Per; Blier Pierre; Möller Hans-Jürgen; Nierenberg Andrew A; Pinder Roger M; Quitkin Frederic M; Reimitz Paul-Egbert; Rosenbaum Jerrold F; Rush A John; Stassen H H; Thase Michael E
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
The Journal of clinical psychiatry 2002;63(8):694-9.
2002: Fava Maurizio; Alpert Jonathan; Nierenberg Andrew; Lagomasino Isabel; Sonawalla Shamsah; Tedlow Joyce; Worthington John; Baer Lee; Rosenbaum Jerrold F
Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
Journal of clinical psychopharmacology 2002;22(4):379-87.
2002: Pollack Mark H; Rapaport Mark H; Fayyad Rana; Otto Michael W; Nierenberg Andrew A; Clary Cathryn M
Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Journal of psychiatric research 2002;36(4):229-36.
2002: Nierenberg Andrew A; Phillips Katharine A; Petersen Timothy J; Kelly Karen E; Alpert Jonathan E; Worthington John J; Tedlow Joyce R; Rosenbaum Jerrold F; Fava Maurizio
Body dysmorphic disorder in outpatients with major depression.
Journal of affective disorders 2002;69(1-3):141-8.
2002: Montoya Alonso; Weiss Anthony P; Price Bruce H; Cassem Edwin H; Dougherty Darin D; Nierenberg Andrew A; Rauch Scott L; Cosgrove G Rees
Magnetic resonance imaging-guided stereotactic limbic leukotomy for treatment of intractable psychiatric disease.
Neurosurgery 2002;50(5):1043-9; discussion 1049-52.
2002: Murphy Jane M; Nierenberg Andrew A; Laird Nan M; Monson Richard R; Sobol Arthur M; Leighton Alexander H
Incidence of major depression: prediction from subthreshold categories in the Stirling County Study.
Journal of affective disorders 2002;68(2-3):251-9.
2002: Yeung A; Neault N; Sonawalla S; Howarth S; Fava M; Nierenberg A A
Screening for major depression in Asian-Americans: a comparison of the Beck and the Chinese Depression Inventory.
Acta psychiatrica Scandinavica 2002;105(4):252-7.
2002: Alpert Jonathan E; Mischoulon David; Rubenstein Grace E F; Bottonari Kathryn; Nierenberg Andrew A; Fava Maurizio
Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2002;14(1):33-8.
2002: Perlis Roy H; Fava Maurizio; Nierenberg Andrew A; Pollack Mark H; Falk William E; Kienke Allison S; Rosenbaum Jerrold F
Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice.
Harvard review of psychiatry 2002;10(2):109-14.
2002: Yeung Albert; Howarth Shauna; Chan Raymond; Sonawalla Shamsah; Nierenberg Andrew A; Fava Maurizio
Use of the Chinese version of the Beck Depression Inventory for screening depression in primary care.
The Journal of nervous and mental disease 2002;190(2):94-9.
2002: Dougherty Darin D; Baer Lee; Cosgrove G Rees; Cassem Edwin H; Price Bruce H; Nierenberg Andrew A; Jenike Michael A; Rauch Scott L
Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder.
The American journal of psychiatry 2002;159(2):269-75.
2002: Petersen Timothy; Dording Christina; Neault Nicole B; Kornbluh Rebecca; Alpert Jonathan E; Nierenberg Andrew A; Rosenbaum Jerrold F; Fava Maurizio
A survey of prescribing practices in the treatment of depression.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):177-87.
2002: Petersen Timothy; Papakostas George I; Bottonari Kathryn; Iacoviello Brian; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients.
Psychiatry research 2002;109(1):9-16.
2002: Murphy Jane M; Nierenberg Andrew A; Monson Richard R; Laird Nan M; Sobol Arthur M; Leighton Alexander H
Self-disparagement as feature and forerunner of depression: findings from the Stirling County Study.
Comprehensive psychiatry 2002;43(1):13-21.
2001: Price B H; Baral I; Cosgrove G R; Rauch S L; Nierenberg A A; Jenike M A; Cassem E H
Improvement in severe self-mutilation following limbic leucotomy: a series of 5 consecutive cases.
The Journal of clinical psychiatry 2001;62(12):925-32.
2001: Lavori P W; Rush A J; Wisniewski S R; Alpert J; Fava M; Kupfer D J; Nierenberg A; Quitkin F M; Sackeim H A; Thase M E; Trivedi M
Strengthening clinical effectiveness trials: equipoise-stratified randomization.
Biological psychiatry 2001;50(10):792-801.
2001: Petersen T; Bottonari K; Alpert J E; Fava M; Nierenberg A A
Use of the five-factory inventory in characterizing patients with major depressive disorder.
Comprehensive psychiatry 2001;42(6):488-93.
2001: Rauch S L; Dougherty D D; Cosgrove G R; Cassem E H; Alpert N M; Price B H; Nierenberg A A; Mayberg H S; Baer L; Jenike M A; Fischman A J
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder.
Biological psychiatry 2001;50(9):659-67.
2001: Thase M E; Nierenberg A A; Keller M B; Panagides J;
Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients.
The Journal of clinical psychiatry 2001;62(10):782-8.
2001: Petersen T; Gordon J A; Kant A; Fava M; Rosenbaum J F; Nierenberg A A
Treatment resistant depression and axis I co-morbidity.
Psychological medicine 2001;31(7):1223-9.
2001: Spillmann M K; Van der Does A J; Rankin M A; Vuolo R D; Alpert J E; Nierenberg A A; Rosenbaum J F; Hayden D; Schoenfeld D; Fava M
Tryptophan depletion in SSRI-recovered depressed outpatients.
Psychopharmacology 2001;155(2):123-7.
2001: Mischoulon D; McColl-Vuolo R; Howarth S; Lagomasino I T; Alpert J E; Nierenberg A A; Fava M
Management of major depression in the primary care setting.
Psychotherapy and psychosomatics 2001;70(2):103-7.
2001: Kornbluh R; Papakostas G I; Petersen T; Neault N B; Nierenberg A A; Rosenbaum J F; Fava M
A survey of prescribing preferences in the treatment of refractory depression: recent trends.
Psychopharmacology bulletin 2001;35(3):150-6.
2001: Iosifescu D V; Howarth S; Alpert J E; Nierenberg A A; Worthington J J; Fava M
T3 blood levels and treatment outcome in depression.
International journal of psychiatry in medicine 2001;31(4):367-73.
2001: Nierenberg A A; Gray S M; Grandin L D
Mood disorders and suicide.
The Journal of clinical psychiatry 2001;62 Suppl 25():27-30.
2001: Nierenberg A A; DeCecco L M
Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression.
The Journal of clinical psychiatry 2001;62 Suppl 16():5-9.
2001: Nierenberg A A
Do some antidepressants work faster than others?
The Journal of clinical psychiatry 2001;62 Suppl 15():22-5.
2001: Nierenberg A A
Long-term management of chronic depression.
The Journal of clinical psychiatry 2001;62 Suppl 6():17-21.
2001: Ochsner K N; Kosslyn S M; Cosgrove G R; Cassem E H; Price B H; Nierenberg A A; Rauch S L
Deficits in visual cognition and attention following bilateral anterior cingulotomy.
Neuropsychologia 2001;39(3):219-30.
2000: Nierenberg A A; Alpert J E
Depressive breakthrough.
The Psychiatric clinics of North America 2000;23(4):731-42.
2000: Rauch S L; Kim H; Makris N; Cosgrove G R; Cassem E H; Savage C R; Price B H; Nierenberg A A; Shera D; Baer L; Buchbinder B; Caviness V S; Jenike M A; Kennedy D N
Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study.
Journal of neurosurgery 2000;93(6):1019-25.
2000: Nierenberg A A; Farabaugh A H; Alpert J E; Gordon J; Worthington J J; Rosenbaum J F; Fava M
Timing of onset of antidepressant response with fluoxetine treatment.
The American journal of psychiatry 2000;157(9):1423-8.
2000: Fredman S J; Fava M; Kienke A S; White C N; Nierenberg A A; Rosenbaum J F
Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.
The Journal of clinical psychiatry 2000;61(6):403-8.
2000: Mischoulon D; Nierenberg A A; Kizilbash L; Rosenbaum J F; Fava M
Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2000;45(5):476-81.
2000: Fava M; Vuolo R D; Wright E C; Nierenberg A A; Alpert J E; Rosenbaum J F
Fenfluramine challenge in unipolar depression with and without anger attacks.
Psychiatry research 2000;94(1):9-18.
2000: Fava M; Rankin M A; Wright E C; Alpert J E; Nierenberg A A; Pava J; Rosenbaum J F
Anxiety disorders in major depression.
Comprehensive psychiatry 2000;41(2):97-102.
1999: Nierenberg A A; Burt T; Matthews J; Weiss A P
Mania associated with St. John's wort.
Biological psychiatry 1999;46(12):1707-8.
1999: Sonawalla S B; Renshaw P F; Moore C M; Alpert J E; Nierenberg A A; Rosenbaum J F; Fava M
Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine.
The American journal of psychiatry 1999;156(10):1638-40.
1999: Sonawalla S B; Spillmann M K; Kolsky A R; Alpert J E; Nierenberg A A; Rosenbaum J F; Fava M
Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
The Journal of clinical psychiatry 1999;60(9):580-3.
1999: Cannon B; Mulroy R; Otto M W; Rosenbaum J F; Fava M; Nierenberg A A
Dysfunctional attitudes and poor problem solving skills predict hopelessness in major depression.
Journal of affective disorders 1999;55(1):45-9.
1999: Fava M; Rosenbaum J F; Kolsky A R; Alpert J E; Nierenberg A A; Spillmann M; Moore C; Renshaw P; Bottiglieri T; Moroz G; Magni G
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder.
Journal of clinical psychopharmacology 1999;19(4):329-35.
1999: Smoller J W; Nierenberg A A
Small numbers, big impact.
Harvard review of psychiatry 1999;7(2):109-13.
1999: Alpert J E; Fava M; Uebelacker L A; Nierenberg A A; Pava J A; Worthington J J; Rosenbaum J F
Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder.
Biological psychiatry 1999;46(2):202-11.
1999: Nierenberg A A; Keefe B R; Leslie V C; Alpert J E; Pava J A; Worthington J J; Rosenbaum J F; Fava M
Residual symptoms in depressed patients who respond acutely to fluoxetine.
The Journal of clinical psychiatry 1999;60(4):221-5.
1999: Tedlow J; Leslie V; Keefe B R; Alpert J; Nierenberg A A; Rosenbaum J F; Fava M
Axis I and Axis II disorder comorbidity in unipolar depression with anger attacks.
Journal of affective disorders 1999;52(1-3):217-23.
1999: Nierenberg A A; Wright E C
Evolution of remission as the new standard in the treatment of depression.
The Journal of clinical psychiatry 1999;60 Suppl 22():7-11.
1998: Tedlow J; Fava M; Uebelacker L; Nierenberg A A; Alpert J E; Rosenbaum J
Outcome definitions and predictors in depression.
Psychotherapy and psychosomatics 1998;67(4-5):266-70.
1998: Nierenberg A
Should you take St. John's Wort?
Health news (Waltham, Mass.) 1998;4(5):4-5.
1998: Nierenberg A A
Shock therapy for depression.
Health news (Waltham, Mass.) 1998;4(2):3.
1998: Nierenberg A A; Alpert J E; Pava J; Rosenbaum J F; Fava M
Course and treatment of atypical depression.
The Journal of clinical psychiatry 1998;59 Suppl 18():5-9.
1998: Fava M; Rankin M A; Alpert J E; Nierenberg A A; Worthington J J
An open trial of oral sildenafilin antidepressant-induced sexual dysfunction.
Psychotherapy and psychosomatics 1998;67(6):328-31.
1998: Nierenberg A A; Dougherty D; Rosenbaum J F
Dopaminergic agents and stimulants as antidepressant augmentation strategies.
The Journal of clinical psychiatry 1998;59 Suppl 5():60-3; discussion 64.
1997: Fava M; Mulroy R; Alpert J; Nierenberg A A; Rosenbaum J F
Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.
The American journal of psychiatry 1997;154(12):1760-2.
1997: Fava M; Uebelacker L A; Alpert J E; Nierenberg A A; Pava J A; Rosenbaum J F
Major depressive subtypes and treatment response.
Biological psychiatry 1997;42(7):568-76.
1997: Alpert J E; Uebelacker L A; McLean N E; Nierenberg A A; Pava J A; Worthington J J; Tedlow J R; Rosenbaum J F; Fava M
Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications.
Psychological medicine 1997;27(3):627-33.
1997: Nierenberg A A; Mulroy R
Declaration of treatment failures.
Modern problems of pharmacopsychiatry 1997;25():17-33.
1997: Fava M; Nierenberg A A; Quitkin F M; Zisook S; Pearlstein T; Stone A; Rosenbaum J F
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
Psychopharmacology bulletin 1997;33(1):101-3.
1996: Fava M; Davidson K; Alpert J E; Nierenberg A A; Worthington J; O'Sullivan R; Rosenbaum J F
Hostility changes following antidepressant treatment: relationship to stress and negative thinking.
Journal of psychiatric research 1996;30(6):459-67.
1996: Worthington J; Fava M; Agustin C; Alpert J; Nierenberg A A; Pava J A; Rosenbaum J F
Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment.
Psychosomatics 1996;37(6):518-22.
1996: Nierenberg A A; Ghaemi S N; Clancy-Colecchi K; Rosenbaum J F; Fava M
Cynicism, hostility, and suicidal ideation in depressed outpatients.
The Journal of nervous and mental disease 1996;184(10):607-10.
1996: Nierenberg A A; Pava J A; Clancy K; Rosenbaum J F; Fava M
Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes?
Biological psychiatry 1996;40(8):691-6.
1996: Tedlow J R; Fava M; Uebelacker L A; Alpert J E; Nierenberg A A; Rosenbaum J F
Are study dropouts different from completers?
Biological psychiatry 1996;40(7):668-70.
1996: Fava M; Alpert J E; Borus J S; Nierenberg A A; Pava J A; Rosenbaum J F
Patterns of personality disorder comorbidity in early-onset versus late-onset major depression.
The American journal of psychiatry 1996;153(10):1308-12.
1996: Demopulos C; Fava M; McLean N E; Alpert J E; Nierenberg A A; Rosenbaum J F
Hypochondriacal concerns in depressed outpatients.
Psychosomatic medicine 1996;58(4):314-20.
1996: Alpert J E; Maddocks A; Nierenberg A A; O'Sullivan R; Pava J A; Worthington J J; Biederman J; Rosenbaum J F; Fava M
Attention deficit hyperactivity disorder in childhood among adults with major depression.
Psychiatry research 1996;62(3):213-9.
1996: Fava M; Abraham M; Alpert J; Nierenberg A A; Pava J A; Rosenbaum J F
Gender differences in Axis I comorbidity among depressed outpatients.
Journal of affective disorders 1996;38(2-3):129-33.
1996: Fava M; Alpert J; Nierenberg A A; Ghaemi N; O'Sullivan R; Tedlow J; Worthington J; Rosenbaum J F
Fluoxetine treatment of anger attacks: a replication study.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 1996;8(1):7-10.
1995: Leiter F L; Nierenberg A A; Sanders K M; Stern T A
Discontinuation reactions following sertraline.
Biological psychiatry 1995;38(10):694-5.
1995: Nierenberg A A; McLean N E; Alpert J E; Worthington J J; Rosenbaum J F; Fava M
Early nonresponse to fluoxetine as a predictor of poor 8-week outcome.
The American journal of psychiatry 1995;152(10):1500-3.
1995: Nierenberg A A; Grossbard S J; Fava M; Rosenbaum J F
Social adjustment does not predict depressive relapse during continuation fluoxetine therapy.
Journal of affective disorders 1995;34(2):73-7.
1995: Fava M; Rappe S M; Pava J A; Nierenberg A A; Alpert J E; Rosenbaum J F
Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose.
The Journal of clinical psychiatry 1995;56(2):52-5.
1995: Worthington J; Fava M; Davidson K; Alpert J; Nierenberg A A; Rosenbaum J F
Patterns of improvement in depressive symptoms with fluoxetine treatment.
Psychopharmacology bulletin 1995;31(2):223-6.
1994: Nierenberg A A; Feighner J P; Rudolph R; Cole J O; Sullivan J
Venlafaxine for treatment-resistant unipolar depression.
Journal of clinical psychopharmacology 1994;14(6):419-23.
1994: Nierenberg A A
The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations?
The Journal of clinical psychiatry 1994;55 Suppl A():55-9; discussion 60-1, 98-100.
1994: Phillips K A; Nierenberg A A
The assessment and treatment of refractory depression.
The Journal of clinical psychiatry 1994;55 Suppl():20-6.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Andrew Nierenberg

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Physiology

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Andrew Nierenberg (preview)

All Publications